Cryoport(CYRX)
HQ US65% share
manufactured · input
CAR-T cryogenic dry shipper
Liquid-nitrogen vapor-phase Dewar containers validated for 7–10 day -196°C transport of autologous CAR-T cell therapy; each patient infusion requires a unique round-trip N=1 shipment.
1
Source countries
1
Companies
1
Goods affected
0
Claims on record
What depends on it
Goods that need this input
1 essential American goods rely on car-t cryogenic dry shipper somewhere upstream in their supply chain.
Where it comes from
Source countries
Share of global supply, by country.
| Country | Share of supply |
|---|---|
| USUnited States of America | 65% |
Who makes it
Supplier companies
1 company produce car-t cryogenic dry shipper.